| Kürzel | Analyse | Material | |
|---|---|---|---|
| TX9 | TX9 Bäume Mix 9 | MATERIAL: Serum, METHODE: LIA | |
| TZ | Thrombinzeit | MATERIAL: Citrat, | |
| UBG | Urobilinogen | MATERIAL: Spontanharn, METHODE: STIX | |
| UBI | Ubichinon (Coenzym Q10) | MATERIAL: Serum; METHODE: HPLC | |
| UBILIPKOR | Ubichinon lipidkorrigiert | MATERIAL: Serum; METHODE: rechnerisch | |
| VAL | Valproinsäure | MATERIAL: Serum/Vollblut, METHODE: FPIA | |
| VANADKR | Vanadium /g Krea i.H. | MATERIAL: Spontanharn, METHODE: | |
| VANADKR_AM | Vanadium /g Krea i.H. (expon.) | MATERIAL: Spontanharn, METHODE:berechnet | |
| VANADU | Vanadium i.H. | MATERIAL: Spontanharn, METHODE: ICP-MS | |
| VANCO | Vancomycin | MATERIAL: Serum/Vollblut; METHODE: FPIA | |
| VCA | Virus capsid antigen | ||
| VDRL | RPR/VDRL qualitativ | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
| VDRLquant | RPR/VDRL quantitativ | MATERIAL: Serum/Vollblut, METHODE: | |
| VEDOLIZU | Vedolizumab Monitoring | MATERIAL: Serum gefroren | |
| VEDOLIZUAK | Vedolizumab-AK (Entyvio) | MATERIAL: Serum gefroren | |
| VENLA | Venlafaxin | MATERIAL: Serum/Vollblut METHODE: LC-MS | |
| VENLA_GES | Venlafaxin+Desmeth.venlafaxin | ||
| VGCCAKN | Ca-Kanal(VGCC)-AK (N-Typ) | MATERIAL: Serum, Methode: RIA | |
| VGCCAKPQ | Ca-Kanal(VGCC)-AK (P/Q-Typ) | MATERIAL: Serum, Methode: RIA | |
| VGKC_AK | Kalium Kanal-(VGKC)-AK | MATERIAL: Serum, Methode: IFT |